GVS111

GVS111 (Noopept) - 60 capsules - 10mg/capsule

GVS-111, also known as Noopept, is a peptide-like compound used in cognitive and neurological research. It is being investigated for its potential interactions with neurochemical signaling systems and synaptic modulation pathways. Its structure and blood–brain barrier permeability have made it a subject of ongoing research interest

GVS-111 (Noopept) is a synthetic dipeptide nootropic that modulates glutamatergic neurotransmission, primarily through positive regulation of AMPA and NMDA receptor signaling, enhancing synaptic plasticity and long-term potentiation (LTP). It increases expression of neurotrophins such as brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF), promoting neuronal survival, dendritic growth, and neurogenesis. GVS-111 also exhibits antioxidant and neuroprotective properties, reducing excitotoxicity and calcium-mediated neuronal damage, while indirectly influencing cholinergic and dopaminergic pathways involved in cognition and memory formation.

/pages/quality-assurance-1

Disclaimer: All products are sold for research purposes only. The available products are not intended for human consumption, personal use, or any form of medical application. These materials are strictly for laboratory research, scientific studies, and educational purposes only (e.g.., lab or university use). Pinnacle Research Labs is not a licensed pharmacy, medical facility, or compounding service, and does not offer products for medical or clinical applications. Pinnacle Research Labs has never and will never make health and/or therapeutic claims. Buy purchasing our products you are agreeing to our terms of services.